Mats Wahlstrom, Director at Coherus BioSciences, Inc. (CHRS), sold 199,976 shares at $0.74 ($148K) on 2025-05-23, disclosed to the SEC on 2025-05-28.
Open-market sale of $148k CHRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.74 | 99,988 | $74K | 50.0% |
| 2 | $0.74 | 99,988 | $74K | 50.0% |
| Total | $0.74 avg | 199,976 | $148K | 100% |
| Filing → |
| TLSI | BUY | 2024-11-22 | $47K | — | Filing → |
| CHRS | SELL | 2020-06-19 | $6.9M | — | Filing → |
| CHRS | SELL | 2020-03-05 | $4.8M | — | Filing → |